Suppr超能文献

趋化因子受体CCR7在同种免疫反应中控制依赖淋巴结的细胞毒性T细胞致敏。

The chemokine receptor CCR7 controls lymph node-dependent cytotoxic T cell priming in alloimmune responses.

作者信息

Höpken Uta E, Droese Jana, Li Jian-Ping, Joergensen Joanne, Breitfeld Dagmar, Zerwes Hans-Günter, Lipp Martin

机构信息

Department of Tumor Genetics and Immunogenetics, Max-Delbrück-Center for Molecular Medicine, MDC, Berlin, Germany.

出版信息

Eur J Immunol. 2004 Feb;34(2):461-70. doi: 10.1002/eji.200324690.

Abstract

The chemokine receptor CCR7 and its ligands regulate migration and colocalization of T cells and mature dendritic cells to and within secondary lymphoid organs. The requirement of CCR7 in efficient priming of allospecific cytotoxic CD8(+) T cells is poorly characterized. Here, we demonstrate a role for CCR7 in the initiation of an alloimmune response and in the development of transplant rejection. Remarkably, in a model of acute allogeneic tumor rejection, CCR7(-/-) mice completely failed to reject subcutaneously injected MHC class I mismatched tumor cells and cytotoxic activity of allospecific T cells was severely compromised. When solid tumors derived from wild-type mice were transplanted, recipient CCR7(-/-) mice were capable of rejecting the allografts. In contrast, tumor allografts transplanted from CCR7(-/-) donors onto CCR7(-/-) recipients showed allograft survival up to 28 days, suggesting a critical function of CCR7 on donor-type passenger leukocytes in the initiation of cytotoxic CD8(+) T cell responses. In a heterotopic heart transplantation model CCR7 deficiency resulted in significantly prolonged but not indefinite allograft survival. Additional prolongation of graft survival was observed when hearts from CCR7(-/-) mice were used as donor organs. Our results define a key role for CCR7 in allogeneic T cell priming within the context of draining lymph nodes.

摘要

趋化因子受体CCR7及其配体可调节T细胞和成熟树突状细胞向二级淋巴器官迁移并在其中共定位。CCR7在高效启动同种异体特异性细胞毒性CD8(+) T细胞方面的需求目前尚不清楚。在此,我们证明了CCR7在同种异体免疫反应启动及移植排斥反应发展过程中的作用。值得注意的是,在急性同种异体肿瘤排斥模型中,CCR7(-/-)小鼠完全无法排斥皮下注射的MHC I类不匹配肿瘤细胞,同种异体特异性T细胞的细胞毒性活性也严重受损。当移植源自野生型小鼠的实体瘤时,受体CCR7(-/-)小鼠能够排斥同种异体移植物。相反,将源自CCR7(-/-)供体的肿瘤同种异体移植物移植到CCR7(-/-)受体上,同种异体移植物可存活长达28天,这表明CCR7在细胞毒性CD8(+) T细胞反应启动过程中对供体型过客白细胞具有关键作用。在异位心脏移植模型中,CCR7缺陷导致同种异体移植物存活时间显著延长,但并非无限期存活。当使用CCR7(-/-)小鼠的心脏作为供体器官时,观察到移植物存活时间进一步延长。我们的研究结果确定了CCR7在引流淋巴结环境中同种异体T细胞启动过程中的关键作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验